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Initial impedance decrease as an indicator of good catheter contact: insights from radiofrequency ablation with two different force sensing catheters Background: Good catheter-tissue contact force (CF) is critical for transmural and durable lesion formation during radiofrequency (RF) ablation, but difficult to assess in clinical practice. CF-sensing catheters have been developed recently. Tissue heating during RF-application results in an impedance decrease at the catheter tip. Methods: We correlated initial impedance decreases with the achieved CF during RF applications in atrial fibrillation ablations with a CF-sensing RF-catheter with stable catheter position and CF during the first 20 seconds. We analyzed 642 RF-applications in 12 patients undergoing ablation with the Tacticath catheter (Endosense) and 562 RF-applications in 21 patients undergoing ablation with the SmartTouch catheter (Biosense-Webster). Results: When RF-applications were analyzed according to an achieved average CF of <10g, 10-20g, and >20g, starting impedance levels were 152 , 150 and 155 with the Tacticath catheter (p=0.12), and 124 , 126 and 131 with the SmartTouch catheter (p=0.001). The initial impedance decreases were significantly larger when greater CF was achieved. The corresponding median values were 3 (IQR -3-7), 7 (4-11) and 11 (7-16) at 10 seconds, and 4 (-4-10), 8 (4-12) and 13 (7-18) at 20 seconds with the Tacticath (p<0.001 between categories), and 6 (IQR 3-9), 9 (6-13) and 11 (7-16) at 10 seconds, and 7 (3-11), 10 (7-16) and 14 (10-19) at 20 seconds with the SmartTouch (p=0.001 between categories). Figure 1 Conclusions: The initial impedance decrease during RF-application is larger when greater catheter contact is achieved, with findings very consistent between two CF-sensing catheters. Monitoring of the initial impedance decrease is a widely available indicator of catheter contact and may help to improve formation of durable ablation lesions.
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The COR trial: a randomized study with continuous rhythm monitoring comparing the efficacy of cryoenergy and radiofrequency for pulmonary vein isolation Background: This is a randomized, single-center study comparing the efficacy of a simplified strategy of pulmonary vein (PV) cryoablation (C) versus standard PV isolation with open-irrigated radiofrequency (R) catheters. Methods and results: 50 patients with drug-refractory paroxysmal AF and 4 independent PVs underwent a Reveal XT ® implantation and randomization to C or R. In patients allocated to group C, PV ablation was performed using a single Arctic Front ® balloon (23 or 28-mm) per patient and two 300-seconds applications per PV. No further applications were delivered for closing residual conduction gaps. Patients allocated to group R underwent PV isolation aiming for bidirectional PV conduction block, using Lasso ® and Navistar ThermoCool ® catheters with the CARTO ® system. The primary endpoint of the study (proportion of patients remaining free from AF recurrences ≥2 min without taking antiarrhythmic drugs at the 12th month from ablation) was met by 48% of patients from group C and 68% of patients from group R (OR 0.43 [95% confidence interval, 0.19 to 1.0]; P=0.05). This difference disappeared after adjustment for the technical result of procedure. In patients who had their 4 PVs blocked at the end of procedure, there was no difference between C and R in the primary end-point (67% versus 68%; P=0.94). See Figure 1 . Background: Percutaneous bilateral pulmonary vein isolation is recommended for symptomatic drug refractory atrial fibrillation (AF). Different robotic devices are available for this procedure although the long term efficacy is not well established. The goal of this observational prospective study is to evaluate the efficacy of pulmonary vein isolation using magnetic navigation comparing to a non robotic conventional ablation. Methods: We studied the 1140 consecutive patients admitted to first AF ablation (same medical team in two centers, one using only magnetic navigation and the other manual approach), 57±11 years old, 71.5% male, 30.1% hypertensive, 70.5% Paroxysmal AF, left atrium volume 97.4±34.7ml. 3D mapping systems (CARTO for magnetic navigation and CARTO or NAV-X for manual approach) and circular Lasso catheter were used in all patients. Follow up included clinical evaluation (with ECG or 24h Holter recording by protocol and driven by symptoms) and phone interview. Success was classified in 3 classes: 1 -free of AF (no clinical or documented AF); 2 -clinical AF (AF symptoms not documented by ECG or 24h Holter recording lasting longer than 30sec); 3 -documented AF (ECG and 24h Holter recording lasting more than 30 sec). Results: Ablation was performed with magnetic navigation in 540pts (47.4%). There were no differences regarding type of AF at presentation (76.5% robotic vs 67.6% conventional, p=NS) but patients in the magnetic navigation group had higher prevalence of hypertension (36.9% vs 16.9%; p<0.001). Magnetic navigation procedure lasted longer (189.3±41.3 min vs 153.5±58.4min, p<0.001) but needing lower fluoroscopy time (15±12 min vs 28±17 min; p<0.001). During an average follow up of 32.2±21.6 months, documented recurrence rates were lower in the magnetic navigation group (18.6% vs 32.1%, p=0.003). There was no difference regarding antiarrhythmic drug treatment (57.8% vs 55.3%, NS). In multivariate analysis, matching for follow up and clinical variables, Left atrial volume (OR 1.01; 95% CI 1.001-1.016; p=0.038) was the strongest predictor of recurrence and magnetic navigation was related to a lower recurrence rate (OR 0.55; 95% CI 0.31 -0.98; p=0.04). Conclusions: In our registry of patients submitted to pulmonary vein isolation, magnetic navigation with Stereotaxis ® used lower fluoroscopy times and was non inferior during long term follow up when compared to manual approach.
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Left atrial radiofrequency isolation for surgical treatment of persistent AF: the value of entrance block as procedural end-point on mid-term rhythm outcome Purpose: Despite improvements in knowledge and devices for surgical treatment of atrial fibrillation (AF), intraoperative assessment of electrical left atrial (LA) isolation during ablation is often missing and when performed, merely consists of exit block assessment. We sought to evaluate the impact of the adoption of the standard EP end-point (entrance block) following ablation on rhythm outcomes. Methods: One hundred seventy-nine (179) consecutive patients with persistent AF undergoing epicardial surgical AF ablation were assigned to 2 groups according to the ablation end-points performed intraoperatively: Group A (n=68, entrance and exit block) and Group B (n=111, exit block only). Median AF duration (Group A=48 months vs Group B=42 months) and LA diameter (Group A=46.5±6.7 vs Group B=49.9.5±7.5) were comparable between the two groups. Age (Group A=62.4±11.2 yrs vs Group B=64.7±8.9 yrs) and female gender (Group A=20/68, 29.4% vs Group B=35/111, 31.5%) were also similar. Longterm rhythm outcome was evaluated by means of 72-hrs ECG-Holter monitoring and/or continuous loop recorders. Results: In Group A, the ablation procedure was targeted to reach entrance and exit block, which was obtained in 89.7% (61/68) and 100% of patients respectively, while in Group B ablation was limited to achieve exit block only, which was obtained in 98.1% (109/111). At a median follow-up of 15 months, stable restoration of sinus rhythm was achieved in a significantly higher percentage of patients with entrance-exit block: Group A=89.7% (61/68) vs Group B=69.3% (77/111) (p=0.02).
Conclusions:
The confirmation of entrance block is associated with a significant better outcome in terms of maintenance of sinus rhythm at mid term indicating a stable electrical isolation and a reduced risk of early reconnections. This strategy should be added to the surgical armamentarium in order to improve outcomes following epicardial, surgical AF ablation.
P505 | BEDSIDE
The effect of treating dormant pulmonary vein conduction on the outcome of cryoballoon ablation Introduction: Pulmonary vein isolation (PVI) is an important treatment modality for atrial fibrillation (AF). Repeated procedures are often necessary due to electrical reconnection of the pulmonary veins (PVs). Dormant conduction (DC) can be revealed after radiofrequency ablation by infusion of adenosine. This study evaluated the incidence of DC after cryoballoon ablation and the effect of performing additional ablation. Methods: Patients with paroxysmal or persistent AF scheduled for a first ablation procedure were included. PVI was performed with a 23 or 28 mm cryoballoon catheter (Arctic Front, Medtronic, Minneapolis, USA), depending on PV size. At least two 5-minute applications were performed for each vein. Thirty minutes after PVI, a 12-24 mg bolus adenosine was injected to establish DC for each vein. In case of DC, additional applications with cryoenergy were performed until DC was absent. A control group that underwent cryoballoon ablation without adenosine infusion was selected. The number of applications and time-to-isolation of the PV and minimum temperature were registered. Efficacy of ablation was established after 3, 6 and 12 months follow-up with ECG and 24-hour Holter recordings. Results: Thirty-four patients were included for cryoablation with adenosine and 62 patients treated with cryoablation without adenosine. Baseline characteristics were comparable between both groups. During the procedure, DC was found in 38% of patients (13/34) and 11% of the PVs (15/135). After a mean follow-up of 11±2 months, a reduced number of patients (18%) had AF-recurrence after ablation with DC testing, compared to 40% after cryoablation only (p=0.02). Both ablation with adenosine (OR=0.26, 95% CI 0.09-0.74) and paroxysmal instead of persistent AF (OR=0.25, 95% CI 0.07-0.93) were found to independently reduce the risk of AF-recurrence at follow-up with univariate and multivariate analysis (p=0.01 and p=0.04 respectively). Univariate analysis showed three predictors of DC: time-to-isolation of the PV (p<0.01), PV isolation during the first freeze (p<0.01) and minimum temperature (p=0.058). After multivariate analysis, only PV isolation during the first freeze was found to independently reduce the risk of DC (OR=0.06, p<0.01). Conclusion: Detection and treatment of dormant PV conduction with adenosine and additional ablation during cryoballoon ablation improves outcome in patients with AF. Absence of PV isolation during the first freeze was associated with an increased risk of dormant conduction.
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Clinical experience with a diaphragmatic electromyographic-guided approach to monitor phrenic nerve integrity during cryoballoon-based atrial fibrillation ablation Background: Despite standard monitoring, phrenic nerve palsy (PNP) remains the most frequent complication associated with cryoballoon ablation for AF, with a recent metanalysis showing an incidence of 6.38%. We sought to characterize our experience using the only method that monitor the electrical activity of the phrenic nerve, the Compound Motor Action Potential or CMAP monitoring of the right hemi-diaphragm for the prevention of PNP. Methods: The records of consecutive patients who underwent cryoballoon-based pulmonary vein isolation between October 2010 and January 2013 were studied. In addition to standard monitoring (abdominal palpation during right phrenic nerve pacing from the superior vena cava at 60 bpm; 20 mAmp; 2 ms), all patients underwent diaphragmatic EMG monitoring using surface electrodes during ablation of the right-sided PVs. Cryoablation was halted if a 30% decrease in the amplitude of the diaphragmatic compound motor action potential (CMAP). Both size and generation of cryoballoon were used, Arctic Front™ Medtronic CryoCath LP until August 2012 and Arctic Front Advance™, Medtronic CryoCath LP since September 2012. Results: One hundred and thirty patients [98 males; 58 years±10] were included. Analysis of CMAP potential during right-sided ablation indicated a significant decrease (30% decrease in amplitude) in 35 patients (27%) and the diaphragmatic motion decreased in 22 of those patients (63%). Signal decrease occurred during RSPV isolation in 28 cases, RMPV in 2 cases and RIPV in 5 cases. A 23mm cryoballoon was used in 63% of cases of CMAP amplitude decrease. In all cases, decrease in CMAP amplitude preceded transient decrease of diaphragmatic motion. There was only 3 case of persistent phrenic nerve palsy, and 2 without recovering within 3 months and one recovered within 5 months. All the veins were isolated despite the shortened application (35/35 veins). When these patients needed a second procedure, only 3/35 (9%) of the right-sided veins were reconnected. Conclusion: Electromyographic phrenic nerve integrity monitoring using the diaphragmatic CMAP is feasible, reliable, and easy to perform. Compared to standard monitoring, diaphragmatic CMAP potentials lowers the incidence of persistent phrenic nerve palsy with 3 case (2%) in this study. This method is the only one which can predict the phrenic nerve palsy before it's happened.
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Incidence and characteristics of phrenic nerve palsy following pulmonary vein isolation with the novel second-generation cryoballoon as compared to the first-generation balloon A. Fuernkranz, S. Bordignon, B. Schmidt, A. Konstantinou, V. Urban, M.C. Boehmer, B. Schulte-Hahn, B. Nowak, J.K.R. Chun. Cardioangiologisches Centrum Bethanien, Frankfurt/M, Germany Purpose: To describe incidence and characteristics of Phrenic Nerve Palsy (PNP) following Pulmonary Vein Isolation (PVI) using the novel secondgeneration cryoballoon with enhanced surface cooling (CB2) as compared to the first-generation balloon (CB1). Methods: 191 consecutive patients with paroxysmal or persistent (< 6 months) atrial fibrillation underwent single-transseptal PVI with the CB2 (last 86 patients) or the CB1 (105 patients, control group) in conjunction with an endoluminal spiral mapping catheter. After successful PVI, one bonus CB application was applied for each PV. The right PN was continuously stimulated by a catheter from the superior caval vein during ablation of the septal PVs. In case of loss or weakening of diaphragm contraction, freezing was immediately stopped and no bonus
